
Sampo Oyj (HLSE:SAMPO) has drawn fresh attention after reporting second quarter 2026 results, with net income of €462 million and basic earnings per share from continuing operations of €0.17.
See our latest analysis for Sampo Oyj.
Sampo Oyj’s latest earnings and the completion of its €206.22 million share buyback tranche come as the stock trades at €9.714, with a 90 day share price return of 4.27% but a year to date decline of 5.14%, while the 3 year total shareholder return of 50.84% points to stronger gains over a longer horizon.
If this insurance stock has your attention after earnings and buybacks, it may be a good time to scan the market for other resilient opportunities using the 112 top founder-led companies
Sampo Oyj has paired a fresh buyback with mixed year to date returns, which puts the spotlight on what investors are paying for each euro of earnings and cash flow. Does the current valuation still skew the risk reward toward buyers?
The most followed valuation narrative puts Sampo Oyj’s fair value at €10.51, modestly above the last close of €9.71, which suggests some upside still priced out.
Strategic focus on core non-life insurance markets, ongoing simplification post-Mandatum spin-off, and successful integration of Topdanmark synergies are leading to stronger capital allocation and higher return on equity (ROE), fueling long-term earnings growth.
Want to understand why this narrative still sees room above today’s share price? The key is how revenue, margins and future earnings all connect in that fair value story.
Result: Fair Value of €10.51 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this Sampo Oyj narrative can be challenged if Nordic focused exposure faces regulatory or economic shocks, or if rising climate related claims pressure future underwriting results.
Find out about the key risks to this Sampo Oyj narrative.
The narrative points to Sampo Oyj trading below a €10.51 fair value, yet the current P/E of 15x is higher than both peers at 13.3x and the European insurance average at 12.5x. The fair ratio sits at 20.7x. This raises the question of whether the market is underpricing quality or simply limiting potential future returns.
See what the numbers say about this price — find out in our valuation breakdown.
Curious whether this mixed picture on Sampo Oyj leans more positive or negative overall? Act while the latest information is fresh and weigh both sides using the 3 key rewards and 1 important warning sign.
If Sampo Oyj has sharpened your focus on valuation and quality, do not stop here. The next move could come from ideas you have not checked yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com